Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-Generation Sequencing and Immunotherapy Biomarkers: A Medical Oncology Perspective.

Archives of pathology & laboratory medicine - 1 Mar 2016

Bernicker Eric

Abstract excerpt

The two most important scientific developments of the past decade regarding therapies for patients with non-small cell lung cancer are the ability to exploit particular genetic mutations with targeted therapies and the discovery of drugs that can help the patient's own immune system attack the cancer. Despite these advances, many patients do not yet benefit from either approach. To maximize patient benefit,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Surveillance

Share to Immunotherapy

Share to Molecular Targeted Therapy

Share to Neoplasm Proteins

Share to Precision Medicine

Source

Identifiers

PMID: 26927719
DOI: 10.5858/arpa.2015-0287-SA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-Generation Sequencing and Immunotherapy Biomarkers: A Medical Oncology Perspective.PMID 26927719Read ↗

Next-generation sequencing and molecular therapy.Semantic proximity Read ↗

Next-Generation Sequencing of Lung Cancers: Lessons Learned and Future Directions.Semantic proximity Read ↗

Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?Semantic proximity Read ↗

Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies.Semantic proximity Read ↗

Recent advance of next-generation sequencing in patients with lung cancer.Semantic proximity Read ↗

Experience with targeted next generation sequencing for the care of lung cancer: Insights into promises and limitations of genomic oncology in day-to-day practiceSemantic proximity Read ↗

Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives.Semantic proximity Read ↗

Recent Advances in Personalized Lung Cancer MedicineSemantic proximity Read ↗

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and OpportunitiesSemantic proximity Read ↗

Current status of molecular diagnostics for lung cancerSemantic proximity Read ↗

Lung cancer genotype-based therapy and predictive biomarkers: present and future.Semantic proximity Read ↗

[Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.